The company plans to submit a U.S. Investigational New Drug (IND) application for refisolone in the first half of 2026 to support Phase II development for menopause symptoms. Future regulatory ...
Goldman Sachs general counsel Kathy Ruemmler has had a storied legal career. As a federal prosecutor, she helped successfully ...